Evidence map›Paper›PMID 37191539›Full record

ArticleMicrobiology spectrum2023

Molecular Characterization of the Convergent Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae Strain K1-ST23, Collected in Chile during the COVID-19 Pandemic.

Felipe Morales-León, Maximiliano Matus-Köhler, Pablo Araya-Vega, Felipe Aguilera, Ignacio Torres, Rodrigo Vera, Camila Ibarra, Sebastián Venegas, Helia Bello-Toledo, Gerardo González-Rocha and 1 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. A systematic review of hypervirulentFrontiers in medicine · 2025
    Pooled it
  2. Article
  3. Article
  4. Multicenter Surveillance ofInfection and drug resistance · 2026
    Article
  5. Frontiers in microbiology · 2026
    Review
  6. Article
  7. Article
  8. Multidrug-resistant hypervirulentFuture microbiology · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Deciphering the gastrointestinal carriage ofInfection and immunity · 2024
    Review
  13. Screening ofAntibiotics (Basel, Switzerland) · 2024
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Felipe Morales-León *Laboratorio de Investigación en Agentes Antibacterianos, Departamento de Microbiología, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción, Chile.
Maximiliano Matus-Köhler *Laboratorio de Investigación en Agentes Antibacterianos, Departamento de Microbiología, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción, Chile.
Pablo Araya-VegaLaboratorio de Investigación en Agentes Antibacterianos, Departamento de Microbiología, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción, Chile.
Felipe AguileraDepartamento de Bioquímica y Biología Molecular, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción, Chile.
Ignacio TorresDepartamento de Bioquímica y Biología Molecular, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción, Chile.
Rodrigo VeraHospital de Urgencia Asistencia Pública, Santiago de Chile, Chile.
Camila IbarraHospital de Urgencia Asistencia Pública, Santiago de Chile, Chile.
Sebastián VenegasHospital de Urgencia Asistencia Pública, Santiago de Chile, Chile.
Helia Bello-ToledoLaboratorio de Investigación en Agentes Antibacterianos, Departamento de Microbiología, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción, Chile.ORCID 0000-0002-9277-4681
Gerardo González-RochaLaboratorio de Investigación en Agentes Antibacterianos, Departamento de Microbiología, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción, Chile.ORCID 0000-0003-2351-1236
Andrés Opazo-CapurroLaboratorio de Investigación en Agentes Antibacterianos, Departamento de Microbiología, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción, Chile.ORCID 0000-0002-6382-7625
University of Concepción · CLHospital Dipreca · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate the genomic features of a carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKp) isolate (K-2157) collected in Chile. Antibiotic susceptibility was determined using the disk diffusion and broth microdilution methods. Whole-genome sequencing (WGS) and hybrid assembly were performed, using data generated on the Illumina and Nanopore platforms. The mucoid phenotype was analyzed using both the string test and sedimentation profile. The genomic features of K-2157 (e.g., sequence type, K locus, and mobile genetic elements) were retrieved using different bioinformatic tools. Strain K-2157 exhibited resistance to carbapenems and was identified as a high-risk virulent clone belonging to capsular serotype K1 and sequence type 23 (ST23). Strikingly, K-2157 displayed a resistome composed of β-lactam resistance genes (

Indexed as

COVID-19Klebsiella InfectionsAnti-Bacterial Agentsbeta-LactamasesCarbapenemsChileHumansKlebsiella pneumoniaePandemicsPlasmidsAnti-Bacterial Agentsbeta-LactamasesCarbapenemscarbapenem resistancecarbapenem-resistant Klebsiella pneumoniaegenomic surveillancehypervirulenceWHO priority pathogens

Identifiers

PMID37191539
PMCPMC10269581
OpenAlexW4376641409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.